EnClear Therapies Funding & Investors
Cambridge, MA
EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the C... Read more
encleartherapies.comTotal Amount Raised: $17,718,332
EnClear Therapies Funding Rounds
Grant
$5,000,000
Grant Investors
National Cancer InstituteNational Institute of Neurological Disorders and Stroke (NINDS)Series Unknown
$718,331
Series A
$10,000,000
Series A Investors
20/20 HealthCare PartnersGlobal Health Sciences Venture FundPeter ThielThiel CapitalPresight CapitalAmgenDolby Family VenturesQuark VentureTachyon VenturesBiovergeSeed
$2,000,000
Seed Investors
Presight CapitalThiel CapitalBiovergeSanford Biosciences
Funding info provided by Diffbot.